NASDAQ:REFRResearch Frontiers Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Research Frontiers, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.92 -0.07 (-2.34 %) (As of 08/13/2020 04:00 PM ET) Add Compare Share Today's Range$2.84Now: $2.92▼$3.0450-Day Range$2.99MA: $3.58▼$5.4452-Week Range$1.66Now: $2.92▼$5.70Volume206,300 shsAverage Volume176,201 shsMarket Capitalization$92.20 millionP/E RatioN/ADividend YieldN/ABeta1.34 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Research Frontiers Incorporated develops and markets technology and devices to control the flow of light worldwide. The company develops and licenses suspended particle device (SPD-Smart) light-control technology to companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, and electronics to power end-products incorporating the film, as well as lamination services for and the end-products, such as windows, skylights, and sunroofs. Its SPD-Smart light-control technology is used in various product applications, including windows, sunshades, skylights, and interior partitions for homes and buildings; automotive windows, sunroofs, sun-visors, sunshades, rear-view mirrors, instrument panels, and navigation systems; aircraft windows; museum display panels and eyewear products; and flat panel displays for electronic products. The company serves automotive, aerospace and marine, and architectural industries. Research Frontiers Incorporated was founded in 1965 and is headquartered in Woodbury, New York.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Research Frontiers. Previous Next 2.3 Community Rank Outperform VotesResearch Frontiers has received 145 “outperform” votes. (Add your “outperform” vote.)Underperform VotesResearch Frontiers has received 174 “underperform” votes. (Add your “underperform” vote.)Community SentimentResearch Frontiers has received 54.55% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Research Frontiers and other stocks. Vote “Outperform” if you believe REFR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe REFR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldResearch Frontiers does not currently pay a dividend.Dividend GrowthResearch Frontiers does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Research Frontiers insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $726,139.00 in company stock.Percentage Held by InsidersOnly 7.60% of the stock of Research Frontiers is held by insiders.Percentage Held by InstitutionsOnly 8.91% of the stock of Research Frontiers is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Research Frontiers is -36.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Research Frontiers is -36.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioResearch Frontiers has a P/B Ratio of 12.70. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.46 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Patent owners & lessors Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:REFR Previous Symbol CUSIPN/A CIK793524 Webwww.smartglass.com Phone516-364-1902Debt Debt-to-Equity Ratio0.12 Current Ratio15.99 Quick Ratio16.00Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.56 million Price / Sales59.10 Cash FlowN/A Price / Cash FlowN/A Book Value$0.23 per share Price / Book12.70Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-3,810,000.00 Net Margins-194.70% Return on Equity-37.70% Return on Assets-32.32%Miscellaneous Employees9 Outstanding Shares31,576,000Market Cap$92.20 million Next Earnings Date11/5/2020 (Estimated) OptionableOptionable $2.92 -0.07 (-2.34 %) (As of 08/13/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive REFR News and Ratings via Email Sign-up to receive the latest news and ratings for REFR and its competitors with MarketBeat's FREE daily newsletter. Research Frontiers (NASDAQ:REFR) Frequently Asked Questions How has Research Frontiers' stock been impacted by COVID-19 (Coronavirus)? Research Frontiers' stock was trading at $2.74 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, REFR stock has increased by 6.6% and is now trading at $2.92. View which stocks have been most impacted by COVID-19. When is Research Frontiers' next earnings date? Research Frontiers is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. View our earnings forecast for Research Frontiers. How were Research Frontiers' earnings last quarter? Research Frontiers, Inc. (NASDAQ:REFR) issued its quarterly earnings results on Thursday, May, 7th. The technology company reported ($0.02) earnings per share for the quarter. The technology company had revenue of $0.36 million for the quarter. Research Frontiers had a negative return on equity of 37.70% and a negative net margin of 194.70%. View Research Frontiers' earnings history. Has Research Frontiers been receiving favorable news coverage? News headlines about REFR stock have been trending negative on Friday, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Research Frontiers earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned news coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Research Frontiers. Are investors shorting Research Frontiers? Research Frontiers saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,990,000 shares, an increase of 15.7% from the May 31st total of 1,720,000 shares. Based on an average trading volume of 167,000 shares, the short-interest ratio is presently 11.9 days. Approximately 8.5% of the shares of the stock are short sold. View Research Frontiers' Short Interest. Who are some of Research Frontiers' key competitors? Some companies that are related to Research Frontiers include Joint (JYNT), Acacia Research (ACTG), Quarterhill (QTRH), Quarterhill (QTRHF), Marathon Patent Group (MARA), Finjan (FNJN), XCel Brands (XELB), Health Discovery (HDVY), MGT Capital Investments (MGTI), Spherix (SPEX), ARC Group (ARCK), Micro Imaging Technology (MMTC), American Restaurant Partners LP Class A Partnership Units (ICTPU), Fortel (ECGP) and Patriot Scientific (PTSC). View all competitors. What other stocks do shareholders of Research Frontiers own? Based on aggregate information from My MarketBeat watchlists, some companies that other Research Frontiers investors own include Chesapeake Energy (CHKAQ), Chesapeake Energy (CHKAQ), Energy Transfer LP Unit (ET), Microvision (MVIS), Immunomedics (IMMU), Blackstone Group (BX), Elite Pharmaceuticals (ELTP), Onconova Therapeutics (ONTX), SeaChange International (SEAC) and Ford Motor (F). Who are Research Frontiers' key executives? Research Frontiers' management team includes the following people: Mr. Joseph M. Harary, CEO, Pres, Gen. Counsel, Sec. & Director (Age 58)Mr. Seth L. Van Voorhees, CFO, VP of Bus. Devel., Treasurer & Pres of VariGuard Bus. Unit (Age 58)Mr. Steven M. Slovak, VP of Technology (Age 57)Mr. Michael R. LaPointe, VP of Aerospace Products (Age 60) What is Research Frontiers' stock symbol? Research Frontiers trades on the NASDAQ under the ticker symbol "REFR." Who are Research Frontiers' major shareholders? Research Frontiers' stock is owned by many different institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (0.25%), New York State Common Retirement Fund (0.08%), American International Group Inc. (0.05%), Virtu Financial LLC (0.05%), FNY Investment Advisers LLC (0.03%) and UBS Group AG (0.03%). Company insiders that own Research Frontiers stock include Darryl Daigle, Gregory George Grimes, Joseph M Harary, Kevin Douglas and Michael R Lapointe. View institutional ownership trends for Research Frontiers. Which institutional investors are buying Research Frontiers stock? REFR stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, New York State Common Retirement Fund, American International Group Inc., Virtu Financial LLC, FNY Investment Advisers LLC, and UBS Group AG. Company insiders that have bought Research Frontiers stock in the last two years include Darryl Daigle, Joseph M Harary, and Kevin Douglas. View insider buying and selling activity for Research Frontiers. How do I buy shares of Research Frontiers? Shares of REFR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Research Frontiers' stock price today? One share of REFR stock can currently be purchased for approximately $2.92. How big of a company is Research Frontiers? Research Frontiers has a market capitalization of $92.20 million and generates $1.56 million in revenue each year. Research Frontiers employs 9 workers across the globe. What is Research Frontiers' official website? The official website for Research Frontiers is www.smartglass.com. How can I contact Research Frontiers? Research Frontiers' mailing address is 240 CROSSWAYS PARK DRIVE, WOODBURY NY, 11797. The technology company can be reached via phone at 516-364-1902 or via email at [email protected] This page was last updated on 8/14/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
